Secondary Prevention of Arteriosclerosis in Lower Limb Vascular Amputees: A Missed Opportunity

European Journal of Vascular and Endovascular Surgery

Volumn 32, Issue 5, 2006, Pages 491-493

  Bradley, L ^a   Kirker, S G B ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Amputation; Peripheral vascular disease; Secondary prevention; Statin

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPOCHOLESTEROLEMIC AGENT; WARFARIN;

ADULT; AGED; ARTERIOSCLEROSIS; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; LEG AMPUTATION; LEG PROSTHESIS; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; PATIENT REFERRAL; PERIPHERAL VASCULAR DISEASE; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SECONDARY PREVENTION; TREATMENT INDICATION;

ADULT; AGED; AGED, 80 AND OVER; AMPUTATION; ANTICHOLESTEREMIC AGENTS; ANTICOAGULANTS; ARTERIOSCLEROSIS; CROSS-SECTIONAL STUDIES; DRUG PRESCRIPTIONS; DRUG UTILIZATION; FEMALE; HUMANS; LOWER EXTREMITY; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; PHYSICIAN'S PRACTICE PATTERNS; PLATELET AGGREGATION INHIBITORS; PRESCRIPTIONS, DRUG; RETROSPECTIVE STUDIES;

EID: 33749327817     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2006.07.005     Document Type: Article

References (27)

1. National Amputee Statistical Database Steering Group. The Amputee Statistical Database for the United Kingdom. 2004.
2. Ness J., and Aronow W.S. Prevalence of coexistence of coronary artery disease, ischemic stroke, and peripheral arterial disease in older persons, mean age 80 years, in an academic hospital-based geriatrics practice. J Am Geriatr Soc 47 10 (1999) 1255-1256
3. Criqui M.H., Denenberg J.O., Langer R.D., and Fronek A. The epidemiology of peripheral arterial disease: importance of identifying the population at risk. Vasc Med 2 3 (1997) 221-226
4. Roth E.J., Park K.L., and Sullivan W.J. Cardiovascular disease in patients with dysvascular amputation. Arch Phys Med Rehabil 79 2 (1998) 205-215
5. McWhinnie D.L., Gordon A.C., Collin J., Gray D.W., and Morrison J.D. Rehabilitation outcome 5 years after 100 lower-limb amputations. Br J Surg 81 11 (1994) 1596-1599
6. Goldman L., Weinstein M.C., Goldman P.A., and Williams L.W. Cost-effectiveness of HMG-CoA reductase inhibition for primary and secondary prevention of coronary heart disease. JAMA 265 9 (1991) 1145-1151
7. West of Scotland Coronary Prevention Study: identification of high-risk groups and comparison with other cardiovascular intervention trials. Lancet 348 9038 (1996) 1339-1342
8. Dey S., and Mukherjee D. Clinical perspectives on the role of anti-platelet and statin therapy in patients with vascular diseases. Curr Vasc Pharmacol 1 3 (2003) 329-333
9. McDermott M.M., Guralnik J.M., Greenland P., Pearce W.H., Criqui M.H., Liu K., et al. Statin use and leg functioning in patients with and without lower-extremity peripheral arterial disease. Circulation 107 5 (2003) 757-761
10. Schillinger M., Exner M., Mlekusch W., Amighi J., Sabeti S., Muellner M., et al. Statin therapy improves cardiovascular outcome of patients with peripheral artery disease. Eur Heart J 25 9 (2004) 742-748
11. Durazzo A.E., Machado F.S., Ikeoka D.T., De B.C., Monachini M.C., Puech-Leao P., et al. Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. J Vasc Surg 39 5 (2004) 967-975
12. Henke P.K., Blackburn S., Proctor M.C., Stevens J., Mukherjee D., Rajagopalin S., et al. Patients undergoing infrainguinal bypass to treat atherosclerotic vascular disease are underprescribed cardioprotective medications: effect on graft patency, limb salvage, and mortality. J Vasc Surg 39 2 (2004) 357-365
13. Abbruzzese T.A., Havens J., Belkin M., Donaldson M.C., Whittemore A.D., Liao J.K., et al. Statin therapy is associated with improved patency of autogenous infrainguinal bypass grafts. J Vasc Surg 39 6 (2004) 1178-1185
14. Robless P., Mikhailidis D.P., and Stansby G. Systematic review of antiplatelet therapy for the prevention of myocardial infarction, stroke or vascular death in patients with peripheral vascular disease. Br J Surg 88 6 (2001) 787-800
15. Hayden M., Pignone M., Phillips C., and Mulrow C. Aspirin for the primary prevention of cardiovascular events: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 136 2 (2002) 161-172
16. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet 348 9038 (1996) 1329-1339
17. Collaborative overview of randomised trials of antiplatelet therapy-II: maintenance of vascular graft or arterial patency by antiplatelet therapy. Antiplatelet Trialists' Collaboration. BMJ 308 6922 (1994) 159-168
18. Girolami B., Bernardi E., Prins M.H., ten Cate J.W., Prandoni P., Simioni P., et al. Antiplatelet therapy and other interventions after revascularisation procedures in patients with peripheral arterial disease: a meta-analysis. Eur J Vasc Endovasc Surg 19 4 (2000) 370-380
19. McDermott M.M., Hahn E.A., Greenland P., Cella D., Ockene J.K., Brogan D., et al. Atherosclerotic risk factor reduction in peripheral arterial diseasea: results of a national physician survey. J Gen Intern Med 17 12 (2002) 895-904
20. Brown L.C., Johnson J.A., Majumdar S.R., Tsuyuki R.T., and McAlister F.A. Evidence of suboptimal management of cardiovascular risk in patients with type 2 diabetes mellitus and symptomatic atherosclerosis. CMAJ 171 10 (2004) 1189-1192
21. Adam D.J., Beard J.D., Cleveland T., Bell J., Bradbury A.W., Forbes J.F., et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet 366 9501 (2005) 1925-1934
22. Siriwardena G.J., and Bertrand P.V. Factors influencing rehabilitation of arteriosclerotic lower limb amputees. J Rehabil Res Dev 28 3 (1991) 35-44
23. Mohler III E.R., Hiatt W.R., and Creager M.A. Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease. Circulation 108 12 (2003) 1481-1486
24. Youssef F., Seifalian A.M., Jagroop I.A., Myint F., Baker D., Mikhailidis D.P., et al. The early effect of lipid-lowering treatment on carotid and femoral intima media thickness (IMT). Eur J Vasc Endovasc Surg 23 4 (2002) 358-364
25. Poldermans D., Bax J.J., Kertai M.D., Krenning B., Westerhout C.M., Schinkel A.F., et al. Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery. Circulation 107 14 (2003) 1848-1851
26. Keech A., Simes R.J., Barter P., Best J., Scott R., Taskinen M.R., et al. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet 366 9500 (2005) 1849-1861
27. British Society of Rehabilitation Medicine. Amputee Rehabilitation: Recommended Standards & Guidelines. 2003.